The differential analysis revealed markedly increased infiltration of cancer-associated fibroblasts, endothelial cells, macrophages, particularly M2 macrophages, and monocytes in high-risk patients, and high CD4+ Th1 cell infiltration, for anti-tumor immune response, in low-risk patients (Fig. 6A to F). This evidence concerns the gene CD4 and cancer.